Mucoangin ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
19ライソゾーム病1

19. ライソゾーム病


臨床試験数 : 899 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2021-002550-82-NL
(EUCTR)
22/12/202230/07/2022Effectiveness of ambroxol for treating children and adults with Gaucher disease type 3Effectiveness of ambroxol in children and adults with Gaucher disease 3: n-of-1 series - ATTACK-GD3 Gaucher disease type 3
MedDRA version: 20.0;Level: HLGT;Classification code 10027424;Term: Metabolic and nutritional disorders congenital;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
Product Name: Ambroxol hydrochloride
INN or Proposed INN: AMBROXOL Hydrochloride
Other descriptive name: Mucoangin
Product Name: Ambroxol hydrochloride
INN or Proposed INN: AMBROXOL HYDROCHLORIDE
Other descriptive name: AMBROXOL HYDROCHLORIDE PH. EUR.
Amsterdam UMCNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
4Phase 3Netherlands